These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39261670)

  • 21. Aqueous cannabidiol β-cyclodextrin complexed polymeric micelle nasal spray to attenuate in vitro and ex vivo SARS-CoV-2-induced cytokine storms.
    Changsan N; Sawatdee S; Suedee R; Chunhachaichana C; Srichana T
    Int J Pharm; 2023 Jun; 640():123035. PubMed ID: 37182795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
    Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
    Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of nasal spray drug absorption influenced by mucociliary clearance.
    Shang Y; Inthavong K; Qiu D; Singh N; He F; Tu J
    PLoS One; 2021; 16(1):e0246007. PubMed ID: 33507973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 1-deamino 8-D-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis.
    Akoğlu E; Görür S; Atik E; Okuyucu S; Sangün O
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1919-22. PubMed ID: 16901550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19.
    Chavda VP; Patel AB; Vora LK; Singla RK; Shah P; Uversky VN; Apostolopoulos V
    Curr Pharm Des; 2022; 28(46):3658-3670. PubMed ID: 36284382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
    Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
    Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciliary beat frequency of in vitro human nasal epithelium measured with the simple high-speed microscopy is applicable for safety studies of nasal drug formulations.
    Tratnjek L; Kreft M; Kristan K; Kreft ME
    Toxicol In Vitro; 2020 Aug; 66():104865. PubMed ID: 32311434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
    Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
    J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin and quercetin co-encapsulated in nanoemulsions for nasal administration: A promising therapeutic and prophylactic treatment for viral respiratory infections.
    Vaiss DP; Rodrigues JL; Yurgel VC; do Carmo Guedes F; da Matta LLM; Barros PAB; Vaz GR; Dos Santos RN; Matte BF; Kupski L; Garda-Buffon J; Bidone J; Muccillo-Baisch AL; Sonvico F; Dora CL
    Eur J Pharm Sci; 2024 Jun; 197():106766. PubMed ID: 38615970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.
    Guareschi F; Del Favero E; Ricci C; Cantù L; Brandolini M; Sambri V; Nicoli S; Pescina S; D'Angelo D; Rossi I; Buttini F; Bettini R; Sonvico F
    Eur J Pharm Sci; 2024 Feb; 193():106673. PubMed ID: 38103657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study.
    Tratnjek L; Simić L; Vukelić K; Knežević Z; Kreft ME
    Eur J Pharm Biopharm; 2023 Nov; 192():136-146. PubMed ID: 37804998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of buffered saline solution on nasal mucociliary clearance and nasal airway patency.
    Keojampa BK; Nguyen MH; Ryan MW
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):679-82. PubMed ID: 15523448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells.
    Campos-Gómez J; Fernandez Petty C; Mazur M; Tang L; Solomon GM; Joseph R; Li Q; Peabody Lever JE; Hussain SS; Harrod KS; Onuoha EE; Kim H; Rowe SM
    Am J Physiol Lung Cell Mol Physiol; 2023 Apr; 324(4):L493-L506. PubMed ID: 36809189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of topical corticosteroids and topical antihistaminics on ciliary epithelium of human nasal mucosa in vitro].
    Hofmann T; Wolf G; Koidl B
    HNO; 1998 Feb; 46(2):146-51. PubMed ID: 9556714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Isotonic Seawater Nasal Spray Containing Chamomile Liquid Extract and Other Isotonic Seawater Nasal Washing Solutions for Allergic Rhinitis.
    Atar Y; Karaketir S; Aydogdu I; Sari H; Bircan HS; Uyar Y; Ekincioglu E; Karaketir SG; Atac E; Berkiten G
    Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):427-434. PubMed ID: 34142567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection.
    Winchester S; John S; Jabbar K; John I
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 33992687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of topical drops and sprays on mucociliary transport time and nasal air flow.
    Bercin S; Ural A; Kutluhan A
    Acta Otolaryngol; 2009 Nov; 129(11):1257-61. PubMed ID: 19863321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal polyps show decreased mucociliary transport despite vigorous ciliary beating.
    Nguyen TN; Koga Y; Wakasugi T; Kitamura T; Suzuki H
    Braz J Otorhinolaryngol; 2024; 90(2):101377. PubMed ID: 38232516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.